CoChat

TSLP, IL‐31, IL‐33 and sST 2 are new biomarkers in endophenotypic profiling of adult and childhood atopic dermatitis

Nygaard, U., Hvid, M., Johansen, C., Buchner, M., Fölster‐Holst, R., Deleuran, M., Vestergaard, C. · 2016 · Journal of the European Academy of Dermatology and Venereology
Cited by 157

The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.

Abstract

Background: Recent years have seen growing interest in identifying new biomarkers in atopic dermatitis (AD) that could serve as indicators of disease severity and predictors of treatment response. Objectives: We compared serum levels of thymic stromal lymphopoietin (TSLP), interleukin(IL)‐31, IL‐33 and soluble(s)ST 2 in AD patients and healthy controls, investigated the possible correlation with disease severity, investigated if other atopic comorbidities could play a role, and assessed their potential as biomarkers in AD. Methods: Using standard enzyme‐linked immunosorbent assay techniques, we measured target serum levels in 71 adults and 61 children with AD, and 31 adult controls. We characterized our cohort by disease severity, radioallergosorbent test status concerning both dietary and inhalant allergens, and anamnestic reports of food allergy, concomitant allergic asthma and/or allergic rhinitis. Results: Serum levels of TSLP, IL‐31 and IL‐33, but not sST 2, were significantly elevated in AD patients compared with controls. In AD patients, both IL‐31 and IL‐33 serum levels were higher in children than in adults, while the opposite was the case for sST 2. We observed no correlation between disease severity and any of the investigated targets. While serum TSLP levels were unaffected by concomitant allergies and atopic comorbidities, serum levels of IL‐31, IL‐33 and sST 2 were affected to a small extent. We found a positive correlation between TSLP, IL‐31 and IL‐33, and an inverse relationship between IL‐33 and sST 2. Conclusions: The studied targets hold little potential as indicators of disease severity. The serum values of our targets show robustness against atopic comorbidities, allergies and changes in disease severity. This robustness strengthens their potential use in biomarker‐based stratification and could be instrumental in identifying subgroups and predicting the possible benefit of therapeutic and prevention approaches.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/jdv.13679

Cites

7 of 7 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 7 references

Cited by

See all 157

Metadata

Authors
Nygaard, U., Hvid, M., Johansen, C., Buchner, M., Fölster‐Holst, R., Deleuran, M., & Vestergaard, C.
Venue
Journal of the European Academy of Dermatology and Venereology
Publisher
Wiley
Published
2016-05-06
Volume
30
Issue
11
Pages
1930-1938
ISSN
  • 0926-9959 (ISSN-L)
  • 1468-3083
OpenAlex
W2346851822
Cited by
157
References
7
FWCI
18.34
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: TSLP, IL‐31, IL‐33 and sST 2 are new biomarkers in endophenotypic profiling of adult and childhood atopic dermatitis. https://app.cochat.ai/papers/10.1111/jdv.13679
The paper
Nygaard, U., Hvid, M., Johansen, C., Buchner, M., Fölster‐Holst, R., Deleuran, M., & Vestergaard, C. (2016). TSLP, IL‐31, IL‐33 and sST 2 are new biomarkers in endophenotypic profiling of adult and childhood atopic dermatitis. Journal of the European Academy of Dermatology and Venereology. https://doi.org/10.1111/jdv.13679

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.